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ABSTRACT 
 
 
 
Pathophysiology and Evaluation of Food Intolerance to Soy Using an Atopic Dog 
Model.  (May 2003) 
Robert Allen Kennis, B.S., Michigan State University; 
D.V.M., Michigan State University 
Chair of Advisory Committee:  Dr. Ian Tizard 
 
 
 The purpose of the study was to test the hypothesis that dogs sensitized to soy 
antigen would produce significantly greater amounts of antigen specific IgE antibody 
compared to a control population before and after challenges with soy, hydrolyzed soy, 
and non-soy diets. Further, we sought to evaluate important allergenic components of 
soy using Western blot analysis.  Lastly, absorption and mucosal function testing using 
inert sugars were evaluated for our sensitized and non-sensitized controls.  
 Eight dogs (6 female, 2 male) were sensitized to whole soy using an established 
protocol.  Seven dogs (3 female, 4 male) roughly age matched were used as controls.  
The dogs were randomly split into three groups.  All dogs were fed an elimination diet of 
egg and Brewer’s rice for six weeks. Samples were collected and each group was fed a 
diet of soy and rice flour, hydrolyzed soy and rice flour, or corn and rice flour for three 
weeks.  Samples were collected and each group was fed the elimination diet followed by 
challenge with each of the diets. Serum was collected and stored for allergen specific 
IgE semi-quantitation and Western blot analysis using whole soy fractionated into 
globulin and whey components.  A solution of monosaccharide and disaccharide sugars 
 iv
was orally administered in a volume determined by weight.  Six hours after 
administration the dogs were catheterized and the entire urine volume was collected for 
measurement of sugar recovery by high pressure liquid chromatography, followed by 
pulsed amphometric detection.   
 There was a statistically significant difference in serum IgE between sensitized 
and control dogs after the elimination diet, and also for each of the challenge diets.  
There were differences detected by Western blot analysis for allergens within the soy 
globulin  and whey fractions  for sensitized dogs compared to control dogs.  There were 
no significant differences between sensitized and control dogs for sugar recovery for any 
of the diets.  We conclude that although there were significant differences in measurable 
IgE between sensitized and control dogs, we were unable to differentiate these groups 
using gastrointestinal mucosal permeability and function testing.   
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CHAPTER I 
INTRODUCTION 
Food allergy is a well recognized entity in veterinary and human medicine1-3. The 
suspectect incidence of affected dogs with clinical dermatologic symptoms may reach 
8% of the general population and is the third most common allergy in dogs4.  Due to its 
importance, an animal model to study food allergy has been sought.  Recent publications 
have indicated that the atopic dog model may be suitable for studying Type I 
hypersensitivity reactions to foods5,6.  Because these dogs are sensitized by subcutaneous 
injections rather than by naturally occurring oral sensitization, the validity of this model 
has been questioned.  The purpose of the study was to evaluate the usefulness of this 
canine model for investigating spontaneously occurring dietary hypersensitivity in dogs. 
 The terminology used to describe adverse reactions to food is confusing.  
Proposed definitions based upon mechanistic classification have been employed in the 
human literature but have not been fully accepted in the veterinary community.  Adverse 
food reactions may be the result of toxic or non toxic mechanisms2.  An example of a 
toxic reaction is the ingestion of bacteria laden food items.  Non toxic reactions depend 
upon individual susceptibilities and may be the result of immune mechanisms due to 
allergic hypersensitivity reactions. Other non toxic reactions may relate to intolerance 
due to pharmacologic properties of that food item.  Strawberries and shellfish may be 
high in histamine and ingestion can lead to urticaria, edema, and anaphylaxis.  An 
__________ 
This thesis follows the style and format of American Journal of Veterinary Research. 
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example of a non-toxic metabolic reaction is the ingestion of molds on grains that mimic 
estrogen hormones.  Lastly, idiosyncratic responses may also occur.  Any and all of 
example of a non-toxic metabolic reaction is the ingestion of molds on grains that mimic 
these reactions may occur in dogs.  Therefore, it is probably more correct to use the term 
adverse food reactions in dogs until further clarification is established.  
It has been suggested that food allergy may be a Type I, Type III, or a Type IV 
hypersensitivity reaction4,7.  Affected dogs may present with a myriad of clinical signs 
involving the skin and/or the gastrointestinal tract.  Clinical signs of skin involvement 
are associated with non-seasonal pruritus.  The distribution pattern of pruritus may 
involve any location on the body.  The most commonly affected locations are the ears, 
face, feet, and inguinal regions8.  Secondary bacterial skin infections are common.  
Occasionally, dogs may present with a history of recurrent otitis externa.  Additional 
clinical signs may include urticarial eruption, fever, malaise, and sometimes seizures8.  
Gastrointestinal signs may include vomiting, diarrhea, and weight loss9.  Some dogs may 
present with both dermatologic signs and gastrointestinal disorders10. Interestingly, dogs 
with food allergy may not be responsive to anti-inflammatory dosages of corticosteroid 
medications8.   Because of the clinical variability, it is hypothesized that there may be 
more than one type of reaction and it may be related to a Type I , IgE- mediated reaction. 
In people, food intolerance probably accounts for the majority of adverse food 
reactions.  Specific IgE mediated immediate hypersensitivity reactions have been clearly 
documented in adults and children2.  These reactions are more prevalent in young 
children and those individuals with atopic disease11.  Clinical symptoms from affected 
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skin, respiratory tract, and gastrointestinal tract may be seen minutes to hours after the 
offending allergen is ingested.  Another clinical entity that is similar to the immediate 
hypersensitivity reaction is the oral allergy syndrome2.  This type of contact reaction 
affects the oropharynx, from a localized release of histamine.  Patients with oral allergy 
syndrome complain of pruritus or a tingling sensation of the mouth, tongue and lips.  
Angioedema or tinnitus may also be present2.  Such symptoms may also be associated 
with pollen allergic individuals reacting to ingested fresh fruits or vegetables due to 
cross reactivity with antigenically similar pollen antigens.  Birch pollen and fresh apples 
share similar antigens12. Cooking the offending food usually prevents oral allergy 
syndrome. 
One of the common presenting signs of dogs with adverse reactions to food is 
pruritus of the face; especially the muzzle and the chin regions.  Owners may observe 
that these clinical signs occur immediately or within hours after eating.  These findings 
are suggestive of a reaction similar to the oral allergy syndrome.  However, most dogs 
eat canned foods or dry kibble that has been heat processed that will alter the allergens. 
Once again, the diversity of clinical findings associated with adverse food reactions may 
suggest multiple etiologies, even in the same affected dog. 
It is interesting to note that adverse reactions to foods in both dogs and humans 
may be associated with dermatologic symptoms.  In humans, it has been shown that 
immunologically active food proteins can enter the circulation and travel to distant 
tissues such as the skin13.  These proteins may stimulate a localized immunologic 
response.  It is hypothesized that altered gastrointestinal permeability may lead to an 
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increase in food origin peptides in circulation.  In dogs it has been demonstrated that 
repair of intestinal permeability and mucosal function has led to the resolution of clinical 
signs in dogs with suspected food allergy14.  Although it has not been shown that food 
peptides are present in circulation in the dog, it is reasonable to assume that they are 
present.  This assumption may explain why some dogs with adverse food reactions 
chew, bite, or lick at their feet. 
Several  methods are used for diagnosis of adverse reactions to food in humans.  
The best established and most reliable diagnostic test is the double blind, placebo-
controlled, oral food challenge (DBPCFC)14-16.  Patients are given gelatin capsules with 
measured amounts of allergen in increasing dosage until early clinical symptoms are 
noted.  Neither the doctor nor the patient is aware of the ingredients until after the test is 
completed15.  The test is accurate for diagnosis of an adverse reaction to a food but, it is  
not specific for IgE- mediated hypersensitivity reactions.  Skin prick testing is frequently 
used as a screening tools for IgE mediated reactions16.  A small amount of allergen is 
placed onto the skin surface and a superficial scratch or prick is made to allow the 
allergen to have contact with the dermis.  If specific IgE antibody is present on mast 
cells in the dermis, the allergen will cross-link the antibiodies which will signal the mast 
cell to degranulate which leads to the release of histamine and other pro-inflammatory 
mediators and results in a wheal or urticaria formation.  Glycerinated histamine and 
glycerine diluent are used as positive and negative controls, with a positive reaction 
defined by the wheal of the allergen becoming at least 3 mm greater than the negative 
control11,16.  Skin prick testing in humans is associated with low sensitivity and high 
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specificity (few false positive reactions) and is used to rule out IgE- mediated food 
hypersensitivity.  This test is frequently used for infants and young children that may not 
be amenable to oral food challenges. Skin prick testing is sometimes used in conjunction 
with patch testing to evaluate delayed reactions11.  The net result is that skin prick testing 
has good negative predictability, especially in young children where IgE mediated food 
hypersensitivity is suspected. 
Serum testing using radioallergen serum testing (RAST) or enzyme linked 
immunosorbant assay (ELISA) methodology is occasionally used as a screening test for 
humans16,17.  In vitro evaluations of allergen specific IgE antibodies and occasionally 
IgG4 antibodies are semi-quantitatively compared to pooled normal sera18-21.  There are 
several disadvantages to this diagnostic procedure.  First of all, it has been shown that 
skin prick test negative, serum ELISA test negative patients demonstrated positive 
reactions to D.B.P.C.F.C.22.  Further, these patients had gastrointestinal biopsy samples 
that were positive for a T-helper 2 cytokine pattern when treated by 
immunohistochemical staining.  These results demonstrated that the IgE- mediated 
reaction can be localized.  Others have hypothesized about the importance of localized 
IgE reactions, including the oral allergy syndrome23,24. Another study demonstrated that 
patients with allergies to pollen, may have high circulating IgE levels specific for food 
antigens without clinical evidence of food allergy25. Together these results make serum 
testing for IgE mediated food allergy less desirable than other diagnostic methodologies. 
The only known diagnostic test to accurately assess IgE- mediated dietary 
hypersensitivity in the dog is the elimination test diet8.  A diet of protein and 
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carbohydrate is prepared from home made novel food ingredients based upon previous 
dietary history.  Ideally, the dog has not eaten either food item for greater than two 
months of its life.  This recommendation is empiric and there is no scientific validity for 
the two month time frame.  The home- cooked diet is to be fed for a minimum of six 
weeks4.  Some contend that a six- week trial may not be long enough as some dogs did 
not show clinical improvement for twelve weeks or longer8.  A home- cooked diet is 
preferred over commercially available diet products as there have been reports of some 
dogs having a relapse in clinical symptoms when commercial diets containing similar 
ingredients were fed4.  There are some concerns about feeding an unbalanced diet for 
this duration of time.  However, development of a nutritional deficiency in adults in this 
period of time would be uncommon26.  Home cooked elimination diets supplemented 
with vitamins and minerals are available27.  Another concern about commercially 
produced dry diets is the processing of ingredients through an extruder.  Various animal 
and vegetable fats and proteins may be used in this processing, without a requirement of 
package listing7.  It has been speculated that a diagnosis of dietary hypersensitivity may 
be missed in about 25% of the cases when a dry dog food is fed due to the addition of 
ingredients in processing7.  Although most clinical dermatologists agree that six weeks 
to eight weeks of a food elimination diet are adequate for a diagnosis, there is not a 
standard protocol available that is internationally agreed upon3.  Regardless of the time 
frame, once a dog has had significant improvement in clinical symptoms, the original 
diet is introduced to see if symptoms return.  The adverse reactions may appear within 
several hours, suggesting an immediate hypersensitivity.  In other cases it may be up to 
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14 days before adverse symptoms develop7.  Once a cause and effect is noted, it is 
desirable to pursue individual food item challenges.  This is accomplished by adding a 
small amount of a freshly prepared ingredient to the elimination diet and assessing the 
clinical response.  The majority of dogs with adverse food reactions react to only one 
food antigen28.  The most common ingredients found in a recent review were beef, corn, 
chicken, and wheat29.   
The elimination test diet is not specific for IgE- mediated hypersensitivity.  Dogs 
suffering from a variety of non-immunologic gastrointestinal diseases and skin diseases 
may show clinical improvement.  Gastrointestinal biopsy is sometimes used to aid in the 
diagnosis of dietary hypersensitivity.  The reaction pattern is generally a mixed 
inflammatory pattern with variable severity and is non-specific9.   
In an attempt to further define the reaction pattern of dogs with dietary adverse 
reactions, the use of the gastroscope to inject allergens into the gastric mucosa has been 
proposed30.  For this procedure, the dog is anesthetized and allergens are dripped onto 
the gastric mucosa or directly injected into the stomach submucosa.  Hyperemia quickly 
develops in dogs suspected of having IgE- mediated hypersensitivity.  Biopsy samples of 
injected regions are similar to biopsy samples of urticaria induced by intradermal skin 
test injections.  Biopsy samples collected at the injection site 48 hours later revealed a 
reaction pattern suggestive of a late-phase IgE- mediated reaction5.  These findings are 
suggestive that a true IgE mediated hypersensitivity maybe taking place.   
Intradermal skin testing (IDST) with whole food proteins has been attempted as a 
diagnostic tool for IgE- mediated dietary hypersensitivity.  Allergens are directly 
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injected into the dermis, along with histamine as a positive control and saline as a  
negative control.  The IDST is similar similar to the skin- prick test used in humans in 
that it has low sensitivity and high specificity29.  Although this test may have usefulness 
as a screening tool, it also has not become widely accepted for the diagnosis of dietary 
hypersensitivity.  This may be because in the dog, clinical symptoms for all adverse 
dietary reactions may have overlapping clinical signs, yet only a small subset are truly 
IgE- mediated hypersensitivity.  Intradermal skin testing is only valid for detecting dogs 
with IgE- mediated reactions. 
Serum testing for allergen specific IgE for foods is commercially available for 
dogs.  The serum assays are either RAST or ELISA and only measures IgE.  Thus, they 
only aid in the diagnosis of those dogs with IgE mediated hypersensitivity.  Although 
these tests are available, one company (Greer Laboratories)  has a disclaimer indicating 
that there may not be any validity to the diagnostic usefulness of this procedure.  Further, 
there have been no published reports documenting circulating IgE specific for food 
allergens in the normal canine population or in dogs with concurrent allergy.  It is 
impossible to speculate on the validity of this diagnostic procedure until adequate 
baseline values are established. 
Another novel approach for diagnosis of dietary hypersensitivity is 
gastrointestinal sugar absorption analysis.  Disaccharide sugars exit the intestinal lumen 
through the tight junctions between cells while monosaccharide sugars exit via a 
transcellular route30.  Sucrose, a disaccharide, is preferentially absorbed through the 
stomach.  Lactulose and L-rhamnose absorption and recovery are a reflection of small 
 9
intestinal permeability30.  The ratio of recovery of lactulose to rhamnose increases with 
mucosal damage. Xylose and methylglucose are absorbed through carrier transport 
mechanisms, thus a reduced absorption and urinary recovery would be related to reduced 
gastrointestinal function14.  The percentage recovery ratio of xylose to methylglucose 
decreases with intestinal disease.  Methylglucose absorption is relatively resistant to 
intestinal damage.  Thus, the ratio goes down because xylose absorption is decreased31.  
Together, these five sugars can assess gastrointestinal permeability and mucosal 
function31.  
 It has been demonstrated that the use of inert sugar testing can be used to 
differentiate dogs with adverse food reactions into those that have food hypersensitivity 
(not specifically IgE- mediated) and those with other gastrointestinal disease.  Dogs with 
improvement in gastrointestinal permeability and mucosal function values after being 
fed an elimination diet were presumed to have dietary hypersensitivity while those 
without improvement had other gastrointestinal disease14.  Although these findings do 
not define the immunologic process of the disease, they demonstrate that sugar 
absorption tests may be useful in ruling out non- immune causes of adverse food 
reactions in dogs. 
The atopic dog model has been used for early investigations of human asthma 
and food allergy5,32,33.  Atopy in dogs has been defined by those exhibiting clinical 
evidence of pruritus when exposed to aeroallergens.  Because it is currently believed that 
these dogs exhibit a Type I, IgE- mediated hypersensitivity, intradermal injections of 
offending allergens will cause a wheal and flare reaction.  Serum testing for IgE with 
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ELISA or RAST are inconsistently diagnostic leading to the suspicion that there may be 
a localized reaction confined to the skin34.   
A colony of highly inbred, mixed breed dogs has been formed because of their 
high levels of circulating IgE.  It has been demonstrated that breeding dogs with high 
IgE levels with other similar dogs yields a population of high IgE producing puppies33.  
This may partially explain why certain purebred breeds have an increased prevalence of 
allergy compared to normal canine populations.  A protocol has been developed to 
sensitize these predisposed allergic dogs to selected allergens including food items6.  
Thus this model may be useful to investigate IgE- mediated aspects of canine food 
allergy.   
Because of the predisposition to develop IgE to various allergens, there is no way 
to prevent sensitization to naturally occurring exposure of inhaled allergens or to dietary 
food items.  Therefore, it is inappropriate to attribute changes in pruritus or the 
gastrointestinal system to only those antigens that the dog was sensitized.  Another 
criticism of the model is that the dogs are selected from a highly inbred group that may 
not represent the diversity of the general canine population. 
The long range goal of the study is to advance the understanding of the 
pathophysiology of canine dietary hypersensitivity.  The central hypothesis is that a 
Type I hypersensitivity reaction is the primary response in canine dietary 
hypersensitivity.  A Type I hypersensitivity is an IgE- mediated process leading to the 
degranulation of mast cells.  Mast cells release histamine and serotonin as the primary 
pro-inflammatory mediators.  When this reaction takes place in the skin, wheal and flare 
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occur.  The gastrointestinal symptoms that occur are not well defined.  However, 
hyperemia may be visible with the aid of a flexible endoscopic examination of the 
gastric mucosa and late phase IgE reactions have been observed on histopathology5.  To 
test the central hypothesis, several additional hypotheses have been developed using the 
atopic dog model.  Clinically healthy, non-sensitized dogs without clinical evidence of 
dietary hypersensitivity will be used as controls. 
Hypotheses: 
1. Hydrolyzed soy protein fed orally, will not induce clinical evidence of 
dietary hypersensitivity in dogs sensitized to whole soy allergen. 
2. Only sensitized dogs will exhibit wheal and flare reactions with 
intradermal injections of aqueous soy allergens. 
3. Only sensitized dogs will have increases in serum IgE to soy when 
orally challenged with whole soy diets.  
4. Only sensitized dogs will exhibit gastrointestinal permeability and 
mucosal function changes when orally challenged with whole soy 
diets. 
 
The rationale for the overall study is to develop baseline knowledge about canine 
dietary hypsesensitivity; specifically, the IgE- mediated aspects of this response. A 
colony of highly inbred, mixed breed dogs with a genetic predisposition toward 
developing high IgE levels is available.  One litter of eight has been sensitized to six 
different food allergens:  soy, beef, corn, chicken, wheat, and cow’s milk.  Preliminary 
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data based upon intradermally injected whole food items indicated that all dogs reacted 
to at least one of the six allergens at a dilution of 1:100.  These dogs are kept in a 
controlled environment, away from other research dogs.  They are maintained on a 
commercial diet of egg and Brewer’s rice because none of the dogs has been sensitized 
to these items.  All of the dogs had clinical evidence of pruritus including interdigital 
erythema, erythematous pinnae, and periorbital alopecia that was self induced.  None of 
the dogs had severe enough pruritus to warrant symptomatic medication.  It is important 
to note that although these dogs were pruritic while being fed an elimination diet, the 
cause of the pruritus may have been due to inhaled allergy.    These dogs are cared for by 
Texas A&M University Laboratory Animal Research Resources (L.A.R.R.) and meet the 
University Laboratory Animal Care Committee standards.  An animal use protocol was 
approved prior to the study, for their humane care. 
It is important to understand the pathogenesis of adverse food reactions so that 
innovative diagnostic and treatment options may be developed.  Additionally, a better 
understanding of dietary hypersensitivity may ultimately lead to the development of 
diets that may prevent development of this problem.  Finally, this animal model was 
developed to aid in the understanding of human food allergy.  Thus, further 
understanding of this model may show that it is a model of naturally occurring dietary 
hypersensitivity that has implications for humans with similar disease. 
The proposed study will evaluate canine adverse food reactions from a 
pathophysiologic view point.  It will explore different soy protein allergens to determine 
which are most antigenic.  Intradermal skin testing and serum ELISA analysis will be 
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evaluated as diagnostic tools for immediate hypersensitivity reactions.  Gastrointestinal 
mucosal permeation and function will be evaluated using orally administered mono and 
disaccharide sugars before and after challenging our study dogs with various diets.  
These characterizations of the model, compared to clinically normal control dogs, will 
also allow for the systematic evaluation of hydrolyzed soy protein as a potentially non-
allergenic canine protein source. 
Specific Aim #1 
 Hydrolyzed soy protein fed orally will not induce clinical evidence of dietary 
hypersensitivity in dog sensitized to whole soy antigen. 
 
 The objective of this aspect of the study is to challenge dogs that were sensitized 
to whole soy allergen with diets containing soy or containing hydrolyzed soy protein and 
demonstrate the extent to which clinical symptoms are elicited.  The working hypothesis 
is that hydrolysis of soy protein will yield a protein of a low molecular weight that will 
not be allergenic in our sensitized dogs.  Further, it is hypothesized that feeding a 
hydrolyzed soy protein diet will not induce adverse clinical symptoms in those dogs not 
sensitized to soy.  Assessment will be made with clinical observation of pruritus or 
vomiting and or diarrhea.  The rationale for this aim is that amelioration of clinical 
symptoms is the ultimate objective of dietary therapy for those dogs exhibiting adverse 
reactions to food, regardless of the underlying mechanisms.  It is expected that only 
those dogs with dietary hypersensitivity will experience clinical symptoms when fed a 
diet with corn or whole soy but not with the hydrolyzed soy diet.   
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Specific Aim #2 
 Only sensitized dogs will exhibit wheal and flare reaction with intradermal 
injections of aqueous soy protein. 
 
 It is believed that only those dogs with clinical dietary hypersensitivity will 
exhibit an IgE- mediated, Type I hypersensitivity reaction.  The objective is to skin test 
the dogs with serial dilutions of antigen, before and after challenging them with the test 
diets.  The hypothesis is that only those dogs sensitized with soy will exhibit a wheal and 
flare reaction to intradermally injected aqueous soy allergen.  The rationale for this 
procedure is to generate statistical information validating this methodology as a 
diagnositic tool.  It is expected that only those dogs sensitized to whole soy will react to 
intradermal injections and those reactions will diminish when a non-soy or hydrolyzed 
soy diet is fed.  
Specific Aim #3 
 Only dogs sensitized with soy will have increased levels of serum IgE when 
challenged with a whole soy diet.  Further, soy allergenic fractions will be evaluated 
using Western Blot immunoassay. 
 
 The objective of this part of the study is to demonstrate that dogs with clinical 
adverse reactions to food develop IgE antibodies specific for soy.  Further, it is expected 
that these IgE antibodies will bind to specific fractions of soy proteins.  The hypothesis 
is that only soy proteins over 20 kDa are antigenic.  The strategy for evaluation will 
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incorporate Western Blot analysis for serum IgE before and after challenge with each 
test diet.  Serum will be evaluated by an outside laboratory for soy specific IgE 
expressed as percent relative value (%R).  The rationale of the study is to demonstrate 
the extent to which IgE antibodies are produced to the individual proteins of soy.  It is 
expected that only those dogs sensitized with soy would develop greater than normal 
baseline amounts of soy specific IgE.  It is also expected that these values would 
increase when a whole soy diet is fed, and decrease when a non-soy or hydrolyzed soy 
diet is fed.  Humans with known soy allergy produce IgE to documented soy proteins 
and it is expected that similar results will be identified for dogs. 
 
Specific Aim #4 
 Only sensitized dogs will exhibit gastrointestinal mucosal permeability and 
function changes when orally challenged with a whole soy diet.  These changes can be 
evaluated via administration and recovery of mono and disaccharide sugar. 
 
 The objective of this section of the study is to administer a solution of five mono 
and disaccharide sugars orally and measure the extent to which each is absorbed by their 
excretion in urine.  The hypothesis is that dogs with clinical evidence of dietary 
hypersensitivity will demonstrate altered gastrointestinal mucosal permeability and 
function when challenged with a whole soy diet.  Specifically, the lactulose to rhamnose 
ratio would increase, demonstrating an increase in gastric mucosal permeability, and the 
xylose to methylglucose ratio would decrease, demonstrating a decrease in mucosal 
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absorption.  Sucrose will be evaluated to assess absorption through the stomach, but is 
expected to be zero throughout the study.  To test the hypothesis, all dogs will be 
evaluated at the end of the wash-out acclimation diet, and after each of the three 
challenge diets.  The purpose is to demonstrate that only those dogs with dietary 
hypersensitivity will have altered gastrointestinal mucosal permeability and function, 
ultimately leading to an increase in absorption of glycoproteins which favors increased 
production of IgE.  It is expected that only those dogs with clinical dietary intolerance 
will have abnormal gastrointestinal permeability and mucosal function.  Further, it is 
expected that those dogs with abnormal gastrointestinal permeability and mucosal 
function values will become normal when a hydrolyzed soy diet is fed. 
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CHAPTER II 
MATERIALS AND METHODS 
Study Design 
 The study was conducted as a twenty seven week cross-over feeding trial.  All 
dogs were fed a diet consisting of pelleted Brewer’s rice and egg for 6 weeks.  By 
definition, the diet was an elimination diet meaning that it contained none of the 
ingredients the study dogs were sensitized to via injection. This diet was complete and 
balanced and was fed at ½ kg. of dry food per dog per day.  Each dog was weighed 
weekly and the amount of food was modified to prevent either weight gain or loss during 
the study. Water was provided ad libidim. At the end of the six week elimination diet, 
samples were collected, intradermal testing and the sugar study was done.  The dogs 
were randomly split into three groups of five, containing both sensitized and non-
sensitized control dogs.  Each group was fed one of the three challenge diets for three 
weeks.  The challenge diets were: 1) hydrolyzed soy and corn starch, 2) whole soy and 
corn starch, and 3) corn and corn starch.  Each of the diets was pelleted and formulated 
to be complete and balanced. Complete nutritional information is provided in the 
appendix. The investigators were blinded with respect to which diet was being fed.  
Provisions were arranged for the care of a dog that may have an adverse reaction to any 
of the diets. Because the study dogs would be consuming food items that they had been 
sensitized to, there was a possibility that vomiting, diarrhea, or anaphylaxis could occur.  
After sample collection and testing, all dogs were again fed the elimination diet for six 
weeks.  The groups were then fed one of the challenge diets for three weeks.  Samples 
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again were collected and testing was performed after the challenge.  This process 
continued until each group consumed all three of the challenge diets.  Samples were 
collected after the first six week elimination diet period and then after each challenge, 
for a total of four collections. 
Study Subjects 
Eight sexually intact dogs (2 male, 6 female) from a single litter were sensitized to six 
food allergens including: corn, beef, chicken, wheat, soy, and cow’s milk.  These dogs 
were from a colony of highly inbred mixed breed dogs selected for their ability to 
produce high levels of serum IgE.  Seven sexually intact, mixed breed, adult dogs (3 
male, 4 female) with no history of adverse food reactions or clinical evidence of illness 
were selected to serve as control dogs.  At the time of the study, all dogs were between 
1.5-2 years of age.   
Dog Sensitization Protocol 
 Dogs were injected on newborn day 1 subcutaneously (SQ) in the left axilla with:  
0.1ml beef 1:10,000 (beef G 1:20, diluted with sterile saline), and 0.05ml alum; 0.1ml 
chicken 1:10,000 (chicken meat G 1:20, diluted with sterile saline) and 0.05ml alum; 
0.1ml corn 1:10,000 (corn food G 1:40, diluted with sterile saline) and 0.05ml alum; 
0.1ml cow’s milk 1:10,000 (cow’s milk G 1:40, diluted with sterile saline) and 0.05 ml 
alum.  The dogs were also injected newborn day 1 subcutaneously (SQ) in the right 
axilla with:  0.1ml house dust mite mix (GS mite mix 1:100 diluted with sterile saline) 
and 0.05ml alum, 0.1ml soybean 1:10,000 (soybean food G 1:40, diluted with sterile 
saline) and 0.05ml alum, 0.1ml Western ragweed mix 1:10,000 (Western ragweed mix 
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1:40, diluted with sterile saline) and 0.05ml alum, and 0.1ml wheat 1:10,000 (whole 
wheat 1:20, diluted with sterile saline) and 0.05ml alum.  All allergens were purchased 
from a single source a as stock solutions and diluted for sensitization.  At ages 3,7, and 
11 weeks of age, the puppies were vaccinated SQ in the dorsal scapular region with 
1.0ml of a modified live virus canine distemper-adenovirus type 2- parainfluenza 
vaccineb.  The vaccine was given not only for preventative health issues, but to serve as 
an immune stimulant to favor a t-helper 2, antibody response that favors the production 
of IgE. One and seven days after each vaccination, the dogs received the same food, 
mite, and pollen allergen extracts SQ (same dosages and site) that they received as 
newborns.  Thereafter, the dogs were given the same allergen extracts SQ (same dosages 
and site) every eight weeks.  Vaccinations were given annually.  During the study, the 
dogs were given the allergens (SQ) immediately prior to feeding the elimination diet of 
each phase of the study (every 9 weeks) for consistency.   
Intradermal skin testing 
 Whole freeze- dried allergens were purchased for each of the tested foods; corn, 
chicken, beef, wheat, soybean, and cow’s milk from Greer Laboratoriesa.  Each was 
diluted to a concentration of 1mg/ml with sterile buffered saline.  Phenol was used in the 
diluent as a preservative.  Serial dilutions were made of each food allergen for testing 
purposes.  The dilutions were:  1:10, 1:100, and 1:1000.  Briefly, 0.5ml of stock diluted 
allergen was added to 4.5ml sterile buffered saline.  The process was continued until the 
testing dilutions were prepared.  Each vial was labeled with a number corresponding to 
each of the food items and the dilution concentration.  Once all testing vials were 
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prepared, they were placed into a bag and randomly placed in order in a testing rack.  
The first sample was always the negative control (sterile buffered saline with phenol) 
and the positive control was histamine phosphate diluted to 1:10,000 in sterile buffered 
saline.  The allergens and positive control were prepared fresh before each testing 
procedure to ensure consistency in potency.  Immediately prior to intradermal testing, 
0.05 ml of allergen was drawn into a syringe with a 26 gauge intradermal bevel needle, 
and placed in numeric order corresponding to the allergen vial. The negative and 
positive controls were always the first and second injections accordingly; however, the 
allergen and dilution were blinded to the investigator.  The code was not broken until the 
completion of the study. 
 Each dog was fasted overnight prior to sedation.  Glycopyrrolate (2.5µg/kg, SQ) 
was given approximately 20 minutes prior to sedation to prevent bradycardia during 
anesthesia.  An indwelling 20gauge 1.5 inch intravenous catheter was placed into either 
the right or left cephalic vein using aseptic technique.  Thiopental 5% (20mg/kg) was 
then administered to achieve sedation enough to allow for intubation.  The dog was then 
intubated with a sterile trachea tube and maintained on isoflurane anesthetic (2%) with  
oxygen using a non-rebreathable system for the procedure.  The lateral chest wall was 
clipped using a #40 clipper blade in an area approximately 8 X 8 cm.  Intradermal 
injections (0.05ml) were made for each allergen and dilution along with the negative and 
positive controls.  After 15 minutes, the size of the wheal was measured along two axis 
and the mean wheal diameter size was recorded.  Each wheal was also evaluated 
subjectively.  A score of 0 was given for the negative control, while a score of 4 was 
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given to the positive control.  The wheal was scored based upon size, color (redness), 
and turgidity, compared to the positive control.  A score of 2 or higher indicated a 
significant positive reaction.  For measured wheals, a mean diameter size greater than 
equal to ½ of the histamine positive control is considered a positive reaction.  The 
subjective score is accepted as a standard for evaluation when the evaluator has expertise 
interpreting these test results.  Descriptive statistics were used to evaluate the data. 
IgE Semi-quantitation 
 At each sample collection time, 12cc of whole blood was collected for soy IgE 
antibodies.  The sample was collected via jugular venipuncture using a 12cc syringe and 
20  gauge needle using aseptic technique.  The blood was transferred to a sterile red-top  
vacutainer and refrigerated until transferred to the laboratory.  The whole blood was 
spun down in a centrifuge and the serum was separated from the blood cells.  Each 
sample was labeled and frozen at -20° C until analyzed together at the end of the study.  
The samples were labeled and shipped cold, on dry ice to Greer Laboratoriesa for 
analysis.  All samples were analyzed blind.  An ELISA was performed and the values 
were expressed as a percentage of relative value (%R) compared to a pooled sample of 
clinically normal dogs.  Reference serum of soy allergic dogs is not available.  A 
Students T-test was used for statistical analysis with a p value of  0.05 considered 
significant. 
Protein Separation and Western Blot Analysis 
 Whole organically grown soybeans (Glycine max spp.soja) were purchased from 
a local store.  The beans were processed in a modified protocol described by 
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Awazuhara18.  The beans were ground in a commercial food mill under a hood to 
prevent inhalation.  5 grams of ground soy was added to 20ml of N-Hexane and agitated 
for 30 minutes.  The sample was poured through a filtering apparatus with a 48 mesh 
size.  The solvent was discarded and the soy powder was re-suspended in 20ml of N-
Hexane, agitated for 1 hour, and again filtered as above.  The soy powder was then 
suspended in 50ml of ultrapure H2O, and gently rocked for 1 hour.  At that time, the 
sample was placed in a Beckman Microfuge at 10,000 x g for 10 minutes.  The sample 
was again filtered through a 48 mesh with suction.  This time the supernatant was saved 
and the soy powder was discarded.  The supernatant was then centrifuged at 10,000 x g 
for 30 minutes at 20°C.  The solution was again filtered, this time with a 2µ pore filter 
with suction.  The sample was transferred to a beaker and adjusted to a pH of 4.6 using 
0.5M HCl.  The sample was again centrifuged at 10,000 x g for 30 minutes at 20°C.  
Whole soy was now fractionated into its two protein classes.  The supernatant was the 
whey fraction and the precipitate was the globulin fraction.   
 Each sample fraction was dialyzed in 4L of ultra pure H2O, refrigerated, with 
gentle stirring, for 3 days.  The dialysis membranes contained 10kD pores.  Samples of 
each fraction (globulin, whey) were transferred to Eppendorff tubes and frozen at -80°C. 
The protein concentrations were determined by using a bicinchoninic acid protein assay 
(Pierce, Rockford IL) and a Dynatech microplate reader (MRX).  The globulin 
concentration was 0.8mg/ml, and the whey was 1mg/ml. 
 Proprietary hydrolyzed soy powder was obtained from Ralston Purina Inc.  The 
powder was finely ground and required no further processing.  The same steps were 
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performed for separation into globulin and whey fractions.  Although the hydrolyzed soy 
apparently had the whey removed, a sample of whey protein was present.   
All four samples (globulin, hydrolyzed globulin, whey, and hydrolyzed whey) 
were again measured for protein content using optical density and computer statistical 
analysis.  The final concentrations were:  globulin 1.82mg/ml, whey 1.79mg/ml, 
hydrolyzed globulin 7.44mg/ml, and hydrolyzed whey 13.34mg/ml. 
Protein Electrophoresis using SDS-PAGE 
 One dimensional SDS-PAGE was performed using a Bio Rad Laboratories  mini-
gel apparatus.  A 15% sodium dodecyl sulfate polyacrylamide gel and stacking gel was 
prepared fresh, as needed for the experiments.  The volume prepared was enough for 2 
gels.  A 10% solution of ammonium persulfate was prepared with anhydrous ammonium 
persulfate granules diluted in sterile water.  In a sterile beaker, 3.75ml of sterile water 
was added to 7.5ml acrylamide/ Bis (30%/0.8%).  3.75ml of 4xTris HCl (1.5M), 
containing 0.4% SDS, at pH 8.8 was added along with 0.05ml of the prepared 10% 
ammonium persulfate solution.  The mixture was set aside while the glass plate 
sandwich was prepared.  1.0mm spacers were used in preparing the mini gels.  
Immediately before pouring the gels, 0.015 ml of Temed was added.  4.5 ml was quickly 
transferred to the glass plate sandwich.  Finally, 3ml of sterile water was placed on the 
solution to remove any bubbles that may have formed.  The gels were allowed to 
polymerize for 30 minutes.  Meanwhile, the 4% stacking gel solution was prepared.  In a 
vial, 3.05ml of sterile water was added to 0.6 ml of acrylamide/Bis (30%/0.8%).  1.25 ml 
of 4x Tris HCl (0.5M), containing 0.4% SDS, at pH 6.8 was added along with 0.05 ml of 
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the prepared 10% ammonium persulfate solution.  Temed 0.015 ml was added 
immediately before pouring. Once the gel was set, the water was poured off.  The 
stacking gel solution was added to the top of the gel.  A 15 well comb was inserted. 
 Proteins were prepared for electrophoresis.  Globulin and whey fractions were 
diluted 1:2  in sample buffer.  The hydrolyzed globulin was diluted 1:4, and the 
hydrolyzed whey was diluted 1:8 in sample buffer.  The samples were placed in a 
boiling water bath for 3 minutes for denaturing.  15µl was placed into each well for 
electrophoresis.  Prestained marker was prepared using 5µl diluted in 100 µl of sample 
buffer.  The marker was added to every 5th lane.   
 The glass plate gel sandwiches were placed into the electrophoresis apparatus 
and the chamber was filled with 1x SDS electrophoresis buffer.  The chamber was then 
attached to a power supply at constant 60 mili-amp current for 35 minutes or until the 
blue dye of the pre-stained marker reached the bottom of the gel.  For evaluation of the 
protein separation, the gels were placed in a container and flooded with 0.1% Coomassie 
blue in 50% methanol and 10% acetic acid (Sigma Chemical Co, St. Louis MO) for one 
hour, with gentle shaking.  The solution was removed and a destaining solution 
containing 10% ethanol, 7% acetic acid, and distilled water was added.  Destaining with 
shaking was performed for 12 hours.  The gel was dried on filter paper.  Staining and 
destaining was not performed when the proteins were to be transferred for 
immunoblotting. 
 Protein electrophoresis was completed as above.  An immunoblot sandwich was 
prepared.  A Scotch-Brite pad (3M Co., St Paul MN) followed by a sheet of filter paper 
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pre-moistened with transfer buffer (0.02 M Tris, 0.15 M NaCl at a pH of 7.4 (Sigma 
Chemical Co. St. Louis MO) with 0.04% NaN3 (Mallinckrodt Inc. Paris KY) as a 
preservative) was placed on the bottom ½ of the cassette.  The gel was gently removed 
from the electrophoresis apparatus and placed on the filter paper.  Transfer buffer was 
used to keep the gel moist.  A pipette was rolled over the gel to remove any air bubbles.  
The transfer membrane was cut slightly larger than the size of the gel to enhance 
complete transfer.  It was placed into 100% methanol for 30 seconds and rinsed three 
times with ultra-pure water.  The membrane was then soaked in transfer buffer until 
being applied on top of the gel.  A pipette was rolled over the membrane and gel to 
remove air bubbles and enhance contact.  A moistened filter paper and sponge were 
stacked on top and the cassette was closed under moderate pressure.  The membrane was 
placed to face the anode (positive side) when placed into the transfer tank. Transfer 
buffer was added to the tank to fill above the level of the cassette.  The tank was attached 
to the power source and run at constant voltage (10 volts) overnight.   
 The membrane remained in the transfer buffer until ready for the immunoblot 
procedure to avoid drying.  To confirm that the proteins were transferred, a sample of the 
membrane was placed in Coomassie blue stain solution for 30 seconds followed by 
rinsing in 10% methanol to decolorize.   
 A blocking solution was prepared using 1.5 grams powdered non-fat milk into 50 
ml of calcium and magnesium free phosphate buffered saline (PBS, GibcoBRL Grand 
Island NY) and 25µl Tween 20 (0.05%).  The solution was gently mixed until 
homogenous.  A solution was prepared for washing using 10% PBS 100mls and 50µl 
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Tween 20.  The transfer membrane was cut to include 5 lanes:  pre-stained marker, 
globulin, hydrolyzed globulin, whey, and hydrolyzed whey. Each piece was placed into 
a shallow tray and 10 ml of the blocking mixture was added with gentle shaking for 2 
hours.  The sample was then washed three times, for 3 minutes with shaking, using the 
washing solution.  The antibody solution was prepared for each dog using a 1:100 
concentration (50µl of serum in 5ml blocking solution) and added to the membrane.  
Samples were shaken for 2 hours.  Again, washing was performed as above.  Goat anti-
canine IgE (Bethel Laboratories) conjugated with alkaline phosphatase was diluted to 
1:2500 (3.2µl in 8ml blocking solution), and 4 ml were added to each sample.  The 
samples were shaken for 1 hour and then again washed.  SigmaFast 5-bromo-4chloro-
3indoyl phosphate / nitro blue tetrazolium (BCIP/NBT) (Sigma Chemical Co., St. Louis 
MO) tablets were diluted (1 tab in 10ml distilled H2O) and 4 ml were added to each 
sample for 1 hour with shaking.  The samples were then washed with distilled H2O to 
stop the reaction and allowed to dry in a dark environment.  Descriptive statistics were 
used to evaluate the data. 
Sugar Absorption Study 
 All dogs were fasted overnight, but were allowed free access to water.  The 
solution containing monosaccharide (methylglucose, rhamnose, xylose) and disaccharide 
(sucrose, lactulose) sugars were prepared freshly each day using tap water.  Each 100 ml 
solution contained 1.0 g methylglucose, 2.5 g L-rhamnose, 2.5 g D-xylose, 10 g sucrose 
and 2.5 g lactulose.  It was iso-osmotic at about 293mOsm.  The volume given to the 
dog was based upon body weight:  dogs less than 20kg received 200ml while dogs 
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greater than 20kg received 400ml of the solution.  The dog was physically restrained 
while a urinary catheter was placed.  All the urine was removed from the bladder.  A 
10ml sample of urine was saved for analysis and 10 µl of 0.1g/L NaN3 (sodium azide) 
was added to each urine sample as a preservative.  The dog was restrained as an 
orogastric tube was placed and the sugar solution was administered.  The dog was placed 
in a metabolic cage for six hours with water withheld.  Following the incubation period 
the dog was re-catheterized and the entire volume of urine was collected.  If the dog had 
urinated in the cage, the urine was collected and measured.  A 10 ml sample was saved 
with 10µl of sodium azide added as a preservative.  After each sample collection period, 
each dog received a single injection of amoxicillin SQ (5mg/kg) to reduce the risk of 
urinary tract infection.   
 Urine samples were processed by the Gastrointestinal Laboratory at Texas A&M 
University.  High pressure liquid chromatography followed by pulsed amperometric 
detection was used for sugar recovery31.  Urinary sugar recoveries were expressed as 
percentage recovery for each sugar.  The lactulose:rhamnose (assessment of 
gastrointestinal mucosal permeability)and xylose:methylglucose (assessment of 
gastrointestinal mucosal absorption) recovery ratios were calculated.  Mean urinary 
recoveries for each sugar and mean urinary recovery ratios were compared between 
sensitized and control dogs using two-tailed T tests and ANOVA. A p- value of 0.05 was 
considered significant. 
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CHAPTER III  
RESULTS 
 The first objective was to evaluate the effect of diet on sensitized and non-
sensitized dogs.  The original diet prepared as the “wash-out” diet (elimination diet) 
consisted of pelleted egg and rice flour.  Although this diet was palatable and did not 
cause any dogs to vomit or to lose weight, all the dogs in the study developed diarrhea.  
All dogs, both sensitized and non-sensitized controls, developed watery feces consistent 
with large bowel diarrhea.  At the end of the 6 week period, samples were collected and 
intradermal skin testing was performed.  A new diet was formulated using Brewer’s rice 
instead of rice flour and the wash-out feeding trial was re-started.  The data from those 
samples were reported (see appendix).  It also provided a chance to determine if further 
modification was required. 
 During the study, after switching to the egg and Brewer’s rice diet for washout, 
none of the control dogs developed diarrhea.   All the sensitized dogs developed diarrhea 
during some phase of the study.  No particular diet was associated with the development 
of diarrhea. In fact, some sensitized dogs developed intermittent diarrhea while on the 
elimination diet.  This was consistent with the prior observations that the sensitized dogs 
had intermittent diarrhea before the study was started.  Thus, no conclusions could be 
made about the effects of the diet on the development of diarrhea.    
Intradermal Skin Testing 
 The specific aim of this study was to test the hypothesis that only those dogs 
sensitized to whole soy allergen would develop wheal and flare reaction consistent with 
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a Type I hypersensitivity reaction.  None of the control dogs developed a clinically 
significant positive reaction to intradermally injected soy antigen at 1:10, 1:100, or 
1:1000 W/V during any phase of the study.  The data were pooled over the entire study 
to evaluate the best testing concentration.  (Table 1)  
It was hypothesized that diet would have an effect on detecting clinically 
significant positive skin test results to soy.  The total number of clinically significant 
reactions throughout the study at any testing concentration was 50. (Table 2)  None of 
the control dogs had positive reactions to soy antigen.  Only one sensitized dog (108) did 
not exhibit any clinically significant reactions to intradermally injected soy throughout 
the study.  Of the 50 positive reactions, 8 occurred after feeding the washout diet (16%), 
14 occurred after the hydrolyzed soy diet was fed (28%), 14 occurred after feeding the 
whole soy diet (28%), and 14 occurred after the corn based diet was fed (28%).   
It was hypothesized that serum IgE specific to soy would increase after a whole 
soy diet was fed, and decrease when a hydrolyzed soy diet, a corn based diet, or an 
elimination diet was fed.  In other words, consuming whole soy would increase IgE to 
soy in sensitized dogs.  Serum levels of IgE to soy were reported as percentage of 
relative value (%R), compared to normal pooled canine serum. (Figure 1) There was a 
statistically significant difference (p=0.0003) between the control dogs and sensitized 
dogs for each diet including the washout diet.   There were no statistically significant 
differences in IgE levels to soy when the washout diet and three challenge diets were 
compared among the sensitized dogs.  The same was true for the non-sensitized control 
dogs.   
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Table 1  Number of clinically significant positive reactions to intradermal injections of soy protein 
at 1:10, 1:100, and 1:1000 W/V dilutions for all diets including the elimination diet, hydrolyzed 
soy, whole soy and corn based diet 
 
Posititve Negative Positive Negative Postitive Negative
Sensitized 25 7 20 12 5 27
Control 0 28 0 28 0 28
Total 25 35 20 40 5 55
1:10 1:100 1:1000
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Table 2  “X” indicates a significant positive reaction to intradermally injected soy antigen at each 
dilution for each diet. Dogs 101-108 were sensitized dogs.  Non-sensitized control dogs did not 
have any significant positive reactions at any time during the study 
 
 
Dogs Total
1:10 1:100 1:1000 1:10 1:100 1:1000 1:10 1:100 1:1000 1:10 1:100 1:1000
101 X X X X X X
102 X X X X X X X X
103 X X X X X X X
104 X X X X X X X X
105 X X X X X X X X
106 X X X X X X X X X X
107 X X X
108
Subtotal 5 2 1 7 6 1 7 6 1 6 6 2
Total 50
Elimination Diet Soy Hydrolyzed Soy Corn
8 14 14 14  
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Figure 1  Box plot comparing ELISA values to soy, represented by relative percentage (%R) 
compared to pooled canine serum, in sensitized versus non-sensitized control dogs.  Diet 1= 
elimination diet, Diet 2= hydrolyzed soy, Diet 3= soy, Diet 4= corn.  The range and median are 
shown. 
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Western Blot Analysis 
 Western blots were performed for each patient after the washout diet and after 
each challenge.  IgE binding was assessed compared to known major IgE binding 
proteins to soy in humans.  Coomassie Blue stain was used on the transfer membrane to 
ensure protein transfer (Fig.2).  Pre-stained molecular markers were used to estimate 
protein bands for the globulin and whey fractions of soy. 
The major protein bands identified in the globulin fraction were 34 kD, 28 kD, 
30 kD, 43-45 kD, and minor bands between 51-90kD.  Because the hydrolyzed fraction 
of the globulin protein produced a smear of protein less than 28 kD, no discrete bands 
were identified.  Whey binding was limited to the LMW and HMW components, and 
inconsistent binding between 37-90 kd.  No discernable binding was present within the 
hydrolyzed whey fraction.  An exceptional example of IgE binding was represented by 
dog 106 after being fed a whole soy diet (Fig 3).  The molecular weight markers are in 
lane 1, the globulin fraction in lane 2, the hydrolyzed globulin fraction in lane 3, the 
whey fraction in lane 4 and the hydrolyzed whey fraction in lane 5. 
 
 
 
 
 
 
 
 34
 
 
 
Figure 2  Coomassie stained membrane of globulin and whey fractions of whole soy.  Molecular 
weigh markers kD are identified on the left lane.  Important allergenic peptides in the globulin 
fraction are the acidic, basic, β, and Gly m Bd 30K.  Important whey components are the high 
molecular weight peptide (HMW) and low molecular weight peptide (LMW) 
  
 
 
 35
 
 
Figure 3  Western blot of serum IgE of sensitized Dog #106, to various fractions of soy.  Lane 1= 
pre-stained markers, Lane 2=globulin fraction of whole soy, Lane 3=hydrolyzed globulin fraction 
of soy, Lane 4=whey fraction of whole soy, Lane6=hydroloyzed whey fraction of soy.  Anti-
canine IgE was labeled with alkaline phosphatase. 
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Sugar Absorption Study 
 The results of the sugar study were expressed in percentages of recovery from the 
total urine collected after 6 hours.  All preliminary samples were zero and served as a 
negative control.  These data are not shown.  Table 3,4,5,and 6 represent the data for 
each dog and each diet over the course of the study.  They represent the washout diet and 
each subsequent challenge diet respectively.  The #101-108 represent sensitized dogs 
while #201-207 represent non-sensitized control dogs. 
 The effect of diet was compared for all dogs (sensitized and non-sensitized 
control dogs) for each sugar using unpaired t-test (Table 7).  There were no statistically 
significant differences for any sugar nor for the lactulose:rhamnose (L:R) or xylose: 
methylglucose (X:M). The following p values were calculated for each sugar. 
It was hypothesized that diet would cause alterations in gastrointestinal mucosal 
permeability and function in sensitized, but not non-sensitized control dogs.  Unpaired t-
tests were used to compare sensitized versus non-sensitized control dogs for each sugar 
and each diet (Table 8).  
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Table 3  Sugar absorption values for each dog after being fed the elimination diet.  Dogs 101-
108 represent sensitized dogs while dogs 201-207 represent controls.  Mr= % methylglucose 
recovery, Rr= % rhamnose recovery, Xr= % xylose recovery, Sr= % sucrose recovery, Lr= % 
lactulose recovery, L/R= calculated ratio of lactulose to rhamnose recovery, X/M= calculated 
ratio of xylose to methylglucose.   
 
Dog
Mr. % Rr. % Xr. % Sr. % Lr. % L/R % X/M %
106 43.83 14.06 27.18 0.00 1.78 0.13 0.62
104 69.12 24.84 36.18 0.00 1.35 0.05 0.52
107 59.47 23.75 30.69 0.00 1.24 0.05 0.52
105 67.51 27.36 40.08 0.00 1.65 0.06 0.59
101 49.04 13.02 32.24 0.00 1.05 0.08 0.66
102 14.46 4.10 10.47 0.00 0.18 0.04 0.72
103 63.24 24.66 38.46 0.00 0.84 0.03 0.61
108 55.66 14.72 36.80 0.00 0.92 0.06 0.66
201 71.76 31.98 38.71 0.00 2.44 0.08 0.54
202 5.60 5.45 4.40 0.00 0.73 0.13 0.79
203 77.63 35.16 39.88 0.00 3.21 0.09 0.51
204 32.41 24.43 29.43 0.00 19.66 0.80 0.91
205 67.68 27.00 36.84 0.00 1.68 0.06 0.54
206 49.89 18.28 31.44 0.00 1.22 0.07 0.63
207 66.19 23.95 42.70 0.00 1.47 0.06 0.65
Normal Range 32.8 - 81.0 17.3 - 42.6 16.0 - 43.8 0.0 - 0.6 1.5 - 5.8 0.05 - 0.15 0.4 - 0.59
Elimination Diet
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Table 4  Sugar absorption values for each dog after being fed the hydrolyzed soy diet.  Dogs 
101-108 represent sensitized dogs while dogs 201-207 represent controls.  Mr= % 
methylglucose recovery, Rr= % rhamnose recovery, Xr= % xylose recovery, Sr= % sucrose 
recovery, Lr= % lactulose recovery, L/R= calculated ratio of lactulose to rhamnose recovery, 
X/M= calculated ratio of xylose to methylglucose.   
 
 
Dog
Mr. % Rr. % Xr. % Sr. % Lr. % L/R % X/M %
106 96.12 48.65 45.54 0.00 3.74 0.08 0.47
104 58.93 23.33 34.13 0.00 6.95 0.30 0.58
107 13.71 9.36 8.39 0.00 0.63 0.07 0.61
105 141.91 60.84 62.56 0.00 4.37 0.07 0.44
101 39.40 10.02 23.18 0.00 0.34 0.03 0.59
102 25.08 7.68 18.75 0.00 1.05 0.14 0.75
103 28.64 12.12 17.64 0.00 2.98 0.25 0.62
108 53.50 14.94 29.77 0.13 0.83 0.06 0.56
201 57.99 22.36 32.94 0.00 1.19 0.05 0.57
202 0.00 0.00 0.00 0.00 0.00 0.00 0.00
203 31.63 14.56 31.19 0.00 2.06 0.14 0.99
204 27.74 9.68 13.48 0.00 1.05 0.11 0.49
205 54.56 17.28 29.61 0.00 1.63 0.09 0.54
206 23.90 9.90 19.50 0.00 0.70 0.07 0.82
207 38.42 14.63 24.62 0.00 1.66 0.11 0.64
Normal Range 32.8 - 81.0 17.3 - 42.6 16.0 - 43.8 0.0 - 0.6 1.5 - 5.8 0.05 - 0.15 0.4 - 0.59
Hydrolyzed Soy
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Table 5  Sugar absorption values for each dog after being fed the whole soy diet.  Dogs 101-108 
represent sensitized dogs while dogs 201-207 represent controls.  Mr= % methylglucose 
recovery, Rr= % rhamnose recovery, Xr= % xylose recovery, Sr= % sucrose recovery, Lr= % 
lactulose recovery, L/R= calculated ratio of lactulose to rhamnose recovery, X/M= calculated 
ratio of xylose to methylglucose.   
 
Dog
Mr. % Rr. % Xr. % Sr. % Lr. % L/R % X/M %
106 32.75 9.41 20.59 0.00 0.78 0.08 0.63
104 49.66 25.29 37.31 0.00 1.50 0.06 0.75
107 40.09 16.91 18.57 0.00 1.90 0.11 0.46
105 58.14 18.70 35.28 0.00 2.38 0.13 0.61
101 34.96 11.59 20.79 0.00 1.35 0.12 0.59
102 54.60 13.28 35.70 0.00 0.68 0.05 0.65
103 69.09 32.95 21.27 0.00 6.05 0.18 0.31
108 92.29 17.29 60.69 0.00 4.35 0.25 0.66
201 58.24 21.94 30.23 0.00 2.06 0.09 0.52
202 124.25 45.67 66.39 0.00 5.80 0.13 0.53
203 110.50 54.40 51.98 0.00 14.25 0.28 0.47
204 0.00 0.00 0.00 0.00 0.00 0.00 0.00
205 52.52 23.50 36.14 0.00 1.95 0.08 0.69
206 46.36 15.71 29.59 0.00 0.92 0.06 0.64
207 40.73 19.80 36.90 0.00 1.86 0.09 0.91
Normal Range 32.8 - 81.0 17.3 - 42.6 16.0 - 43.8 0.0 - 0.6 1.5 - 5.8 0.05 - 0.15 0.4 - 0.59
Whole Soy
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Table 6   Sugar absorption values for each dog after being fed the corn based diet.  Dogs 101-
108 represent sensitized dogs while dogs 201-207 represent controls.  Mr= % methylglucose 
recovery, Rr= % rhamnose recovery, Xr= % xylose recovery, Sr= % sucrose recovery, Lr= % 
lactulose recovery, L/R= calculated ratio of lactulose to rhamnose recovery, X/M= calculated 
ratio of xylose to methylglucose.   
 
Dog
Mr. % Rr. % Xr. % Sr. % Lr. % L/R % X/M %
106 40.31 14.28 22.77 0.00 2.07 0.14 0.56
104 60.65 26.72 34.52 0.00 1.76 0.07 0.57
107 15.51 9.78 6.53 0.00 1.27 0.13 0.42
105 29.96 19.74 32.76 0.00 1.96 0.10 1.09
101 113.04 31.24 67.60 0.00 1.64 0.05 0.60
102 27.18 10.68 6.44 0.00 0.90 0.08 0.24
103 46.06 16.17 28.00 0.00 0.63 0.04 0.61
108 8.13 7.13 5.06 0.00 0.81 0.11 0.62
201 68.46 35.82 33.21 0.00 2.43 0.07 0.49
202 0.00 0.00 0.00 0.00 0.00 0.00 0.00
203 50.75 16.50 32.33 0.00 1.59 0.10 0.64
204 31.58 12.70 14.69 0.00 0.99 0.08 0.47
205 59.17 22.11 31.72 0.00 2.82 0.13 0.54
206 35.48 12.86 22.73 0.00 0.98 0.08 0.64
207 59.46 23.91 36.78 0.00 1.64 0.07 0.62
Normal Range 32.8 - 81.0 17.3 - 42.6 16.0 - 43.8 0.0 - 0.6 1.5 - 5.8 0.05 - 0.15 0.4 - 0.59
Corn diet
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Table 7  Pooled data for all dogs for percentage recovery of each sugar and each diet.  Values 
represent the mean value for each sugar.  P values were calculated for each sugar using 
Student’s T tests.  There were no statistically significant differences. Mr= % methylglucose 
recovery, Rr= % rhamnose recovery, Xr= % xylose recovery, Sr= % sucrose recovery, Lr= % 
lactulose recovery, L/R= calculated ratio of lactulose to rhamnose recovery, X/M= calculated 
ratio of xylose to methylglucose.   
 
 
Mr % Rr % Xr % Sr % Lr % L/R % X/M %
Elimination 52.90 20.90 31.70 0.00 2.63 0.12 0.63
Hydrolyzed Soy 46.10 18.40 26.10 0.00 1.95 0.10 0.58
Soy 57.60 21.60 33.40 0.00 3.06 0.11 0.56
Corn 43.10 17.30 25.00 0.00 1.43 0.08 0.54
P Value 0.51 0.72 0.30 0.00 0.54 0.84 0.63
All Dogs Mean Vaules
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Table 8  P values were calculated using unpaired Student’s T test.  Each value represents the 
comparison of sensitized to control dogs for each sugar and each diet throughout the study.  
There were no statistically significant differences (p=0.05).  Mr= % methylglucose recovery, Rr= 
% rhamnose recovery, Xr= % xylose recovery, Sr= % sucrose recovery, Lr= % lactulose 
recovery, L/R= calculated ratio of lactulose to rhamnose recovery, X/M= calculated ratio of 
xylose to methylglucose.   
 
 
Mr. % Rr. % Xr. % Sr. % Lr. % L/R % X/M %
Sensitized
Control
Hydrolyzed Sensitized
Soy Control
Sensitized
Control
Sensitized
Control 0.83
Soy
Corn 0.00
0.30
0.32
0.98
0.920.58
0.08
0.44
0.20
0.74
0.23 0.49 0.23
0.30 0.00 0.59
0.34 0.33 0.54 0.00
Elimination 0.98 0.26 0.95
P Values
0.20 0.23 0.500.00
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CHAPTER IV 
DISCUSSION AND CONCLUSIONS 
The first specific aim of the study was to evaluate the clinical effects of feeding a 
hydrolyzed soy protein diet to dogs sensitized to whole soy.  It was not possible to 
determine that diet had an effect on clinical symptoms.  This was because all of the 
sensitized dogs had diarrhea of varying degrees on all of the diets including the 
elimination washout diet. None of the non-sensitized control dogs developed diarrhea or 
skin signs during any phase of the study. There were no observable changes in skin signs 
including pruritus throughout the study.  All of the sensitized dogs had mild pruritus and 
none developed secondary bacterial infections or otitis.  Dogs with clinical evidence of 
food hypersensitivity usually have moderate to severe pruritus with secondary 
complications.  From the observable changes in the atopic dog model, it can be 
concluded that they did not represent spontaneously occurring dietary hypersensitivity 
associated with skin signs in the canine population.   
 Dogs with clinical evidence of dietary hypersensitivity usually improve when fed 
an elimination diet when diarrhea is the primary sign.  This model did not demonstrate 
clinical improvement in diarrhea when fed an elimination diet or hydrolyzed soy diet.  
This may be because the elimination diet was fed for only six weeks and may have not 
been long enough.  Another possibility is that the sensitized dogs had other 
gastrointestinal illness not relating to dietary hypersensitivity.  From the clinical 
observations it was concluded that the atopic dog model did not share characteristics of 
dogs with clinical dietary hypersensitivity. 
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 The results of the intradermal skin testing using soy antigen indicated that there 
was high sensitivity and also high specificity for the dogs in this study.  Only those dogs 
that were sensitized to soy antigen exhibited clinically significant wheal and flare when 
injected with whole soy antigen.  The results also demonstrated that at the 1:10 
concentration there was 84% sensitivity.  Sensitivity decreased with increased dilution 
factors.  Specificity at all concentrations was 100%.  It is intuitively obvious that higher 
concentrations would yield more clinically significant positive reactions.  It is also 
reasonable to expect that there might be some false positive reactions at higher 
concentrations but this was not the case in the seven non-sensitized control dogs.  These 
data are directly in conflict with those in the literature indicating that intradermal testing 
in both humans and dogs is highly specific but not very sensitive2,34.  The sample size in 
this study was very small (15 dogs) and may not represent the true population.  Also, our 
model is developed from dogs sensitized to soy by subcutaneous injections compared to 
the humans and dogs in the aforementioned studies that were sensitized by the oral route.  
There may be a clinically significant difference between the induction of IgE production 
by injection compared to oral route.  This can be explored further using the same colony 
of dogs used for the study and comparing the changes in specific IgE to food items 
administered orally or injected as in our current model.  Nonetheless, from the current 
data it could be concluded that the best sample concentration for intradermal skin testing 
is 1:10 because it represented the concentration with both the highest sensitivity and 
specificity.  But because this test only detects the IgE mediated aspect of dietary 
hypersensitivity, it has little value in a clinical setting. 
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 None of the non-sensitized control dogs had any clinically significant reactions to 
intradermal injections of soy antigent at any dilution during the study.  False positive 
reactions were not a concern at these testing dilution concentrations.  None of the 
sensitized dogs had reactions at weaker dilutions (1:1000 W/V) without concurrently 
having a positive reaction to the stronger concentrations.  Because all the samples were 
blinded, these data demonstrate that greater sensitivity is seen at higher concentrations of 
injected soy antigen.  When comparing the number of clinically significant positive 
reactions to soy, diet did not appear to have an impact.  This may be due to the route of 
administration of the sensitizing antigen.  Although our sensitized dogs produced 
significantly higher levels of soy specific IgE compared to the control population, oral 
challenges made no significant difference.  This may be because the oral administration 
did not induce the production of circulating soy- specific IgE.  Recent studies in humans 
have shown that there can be significant production of specific IgE in the gut without 
concurrent increases in circulating antibodies22.  An alternative explanation is that 
injected antigen is more likely to produce circulating antigen specific IgE than when 
given by the oral route.  It is this that makes the strongest argument that the atopic dog 
model is not representative of the at-large population of dogs with dietary 
hypersensitivity. 
 One of the sensitized dogs (#108) did not exhibit any wheal and flare to any 
injection of soy antigen during the study.  The likely reason for this is twofold. First, it is 
expected that there is heterogeneity within any sample population, even within the same 
litter.  Dog #108 may be an outlier with respect to her ability to produce IgE specific to 
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soy compared to her littermates.  A simple evaluation of her ELISA values (mean 133, 
sensitized group mean 120) did not demonstrate that her IgE %R to soy were lower than 
her littermates.  The alternative explanation for the lack of positive reactions to 
intradermal skin testing is more likely due to her “stress” associated with the study and 
testing procedures.  Endogenous cortisol can be released during anesthesia that can 
suppress the ability of mast cells to undergo degranulation.  Overall, she had weaker and 
fewer clinically significant positive reactions to any of the tested antigens than her 
littermates.  Her positive controls were adequate for testing evaluation.  However, the 
intradermal injection of histamine is not the same as the ability of mast cells to 
degranulate and release histamine leading to wheal and flare reaction.  There may have 
been differences in the amount of mast cells present within her skin or differences in 
those cells to regenerate histamine after degranulation takes place.  These changes are 
independent of the observation that she had circulating levels of soy specific IgE based 
upon ELISA testing.  Intradermal skin testing alone may be inadequate to detect 
elevations in IgE.  
ELISA values were compared for each diet over the course of the study (Figure 
1).  Although there may have been a trend toward an increase in %R after feeding the 
soy based diet, there was no statistically significant differences.  These data correlate 
with the findings of our intradermal skin testing results.  There were significant 
differences between the sensitized and non-sensitized control dogs but there was no 
effect of diet.  Because the ELISA results and the intradermal skin tests yielded similar 
results, it is reasonable to surmise that either test would be acceptable to differentiate 
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sensitized from non-sensitized control dogs.  There is no data to support that these 
results can be extrapolated to the whole canine population.  Serum ELISA values are 
ineffective as a tool for detecting dietary hypersensitivities in dogs34.  This may be 
because those dogs with clinical dietary hypersensitivity do not have high levels of 
circulating IgE.  Comparing the ELISA values of this study with clinically affected dogs 
may clarify if any differences exist.  Additionally, the small number of sensitized dogs in 
this study precluded extrapolation to the canine population at large.  
 Serial dilutions of soy globulin, whey, hydrolyzed soy, and hydrolyzed whey 
were run on 15% SDS-PAGE to optimize protein separation (data not shown).  Samples 
of a known high IgE producing, sensitized dog were used to titrate the appropriate 
amount of serum to optimize visualizing the binding patterns.  Because a known reactor 
was used and samples were titrated downward, the specificity was increased but 
sensitivity may have been compromised.  The final serum dilution used for the study was 
1:100 in blocking solution.  It was interesting to note that some of the human studies 
incubated the Western blots with 3ml of whole serum18.  This made overall comparisons 
with our study very difficult.    
 Western blot analysis results were compared to known major IgE binding 
proteins in soy in soy allergic humans.  The allergenicity of soybeans is known to reside 
in the protein fractions and at least 16 soybean proteins ranging in size from 14 kD to 70 
kD are recognized as major allergens in humans35. These proteins can be divided into the 
globulin fraction and whey fraction.  The globulin fractions are divided into four 
components (2S, 7S, 11S, and 15S) based upon ultracentrifugation36.  The whey 
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component makes up about 10% of the total soy protein.  It also contains several 
biologically active proteins and enzymes, such as hemagglutinin, urease, and part of the 
2S fraction, including trypsin inhibitors37,38.  These proteins and enzymes are not likely 
to induce clinical allergy. 
 The two major globulin protein components are the 7S and 11S fractions.  β-
conglycinin is the major 7S globulin protein and accounts for about 50% of the 7S total 
fraction and about 20% of the soluble protein fraction36.  It is a trimer composed of three 
major subunits with molecular weights of 76 kD, 72 kD, and 53kD.  Many of the 
sensitized and non-sensitized control dogs exhibited binding to one or more of these 
proteins.  The 11S globulin fractions account for about 40-50% of the total storage 
proteins in soybeans.  They consist of the acidic and basic subunits of glycinin and have 
corresponding molecular weights of about 37 kD and 22 kD 36.  Studies on soy allergic 
humans have shown these proteins to be weakly allergenic 38 and the results of our data 
concur.   
 The strongest binding patterns were at the 33-35 kD site which corresponds to 
the 7S globulin fraction.  Another band at about 30 kD represents a unique 7S globulin 
fraction protein called Gly m Bd 30K.  The last 7S globulin fraction that was important 
in this study was at about 28 kD.  In one study Ogawa identified humans with IgE 
binding to proteins in soybeans and the frequency among the patients with atopic 
dermatitis.  The frequency of binding was 15.9% (33-35 kD), 65.2% (30 kD), and 23.2% 
(28 kD) accordingly35.  Five of the sensitized dogs had binding to these proteins.  In 
another study of soy allergic humans, 50% of the patients had binding to a protein at 
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about 31 kD 18.  This protein may have represented Gly m Bd 30K as it was discovered 
after the aforementioned study.  Together these data support the importance of the 7S 
globulin fractions as important allergens in both humans and sensitized dogs.   
 There were very few proteins identified in the globulin fraction of soy that were 
less than 20 kD.  Proteins smaller than this size are believed to be less allergenic.  When 
hydrolyzed soy was processed in a similar manner as whole soy, and SDS-PAGE was 
performed, a streak of proteins less than 35 kD was present.  The majority of the protein 
was seen less than 20 kD all the way to the bottom of the gel.  No distinct banding was 
seen.  When Western blot analysis was performed on the hydrolyzed soy fraction, IgE 
binding did occur.  This was most likely due to these smaller protein fragments retaining 
antigenic epitopes of the larger 7S proteins.  It could not be concluded that hydrolyzed 
globulin proteins were less allergenic. 
 The whey fraction of soy was less allergenic based upon the intensity of bands of 
both sensitized and non-sensitized control dogs.  There was some binding at the LMW 
and HMW bands but because of the large size of these protein bands, there may have 
been some background reaction with the conjugate.  It was interesting to note that some 
protein bands were present on SDS-PAGE above 31 kD.  Some studies do not recognize 
proteins of this size as part of the whey fraction18,35 while others discuss the importance 
of whey proteins at 41 kD, 58 kD, 75 kD, and 91 kD as allergenic 18.  The findings of 
our study support the findings of the latter.  This may be due to the use of similar 
methodology used for the separation of the globulin and whey fractions.  IgE specific for 
these proteins was only demonstrated in the sensitized dogs.  Overall, the whey fraction 
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was not as allergenic as the globulin fraction in sensitized dogs, and there were few 
positive bands for the non-sensitized dogs for either soy component. 
 The hydrolyzed soy protein was processed into globulin and whey fractions in a 
similar manner as whole soybeans.  This proprietary sample apparently had the whey 
component removed by the hydrolyzation process.  Protein could be detected by the 
protein assay but could not be demonstrated on SDS-PAGE.  Most likely, the proteins 
present were small peptides that migrated off of the 15% gel. The proteins can be run at 
higher percentage gels to better define the molecular weight  of the hydrolyzed whey 
fraction.  No binding to serum IgE was present at any phase of the study.   
 It was hypothesized that dogs sensitized to soy antigen would exhibit 
gastrointestinal changes associated with gastric permeability and mucosal function.  All 
dogs (sensitized and non-sensitized controls) were pooled to evaluate the effect of diet 
on sugar recovery for the five sugars and L:R and X:M ratios.  There was no statistically 
significant difference (p<0.05) for any diet, for each sugar (Table 7).  The next 
evaluation was to compare sensitized dogs to non-sensitized control dogs for each sugar 
and each diet (Table 8).  There were no statistically significant differences (p<0.05).   
 Gastrointestinal mucosal permeability and function testing using sugar solutions 
did not reveal statistically significant differences between the two groups of dogs.  Thus, 
the explanation for the differences in IgE to soy between the groups is likely not because 
of increased damage and increased absorption of soy antigen.  Further, soy allergic dogs 
did not exhibit mucosal function changes after being fed soy diet.  The rational 
explanation for the differences in IgE to soy must be because of the route of sensitization 
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(injection).  It was demonstrated in previous studies that dogs with dietary 
hypersensitivity developed normal values after being fed an elimination diet14.  The 
current study did not demonstrate differences among sensitized versus control dogs, or 
differences based on diet.  The conclusion is that the atopic dog model is different than 
clinically affected dogs with dietary hypersensitivity.  This atopic model demonstrates 
differences in IgE to soy between sensitized and non-sensitized control dogs independent 
of diet, but not due to gastrointestinal mucosal permeability and function testing. 
 Methylglucose is actively transported in the small intestine and is relatively 
resistant to intestinal damage.  This sugar recovery percentage is an assessment of 
absorptive capacity.  By itself methylglucose is not an assessment of intestinal mucosal 
function.  Xylose is also actively transported and absorption decreases with disease. 
When methylglucose absorption is compared to xylose absorption in the ratio of X:M, 
the ratio provides a more useful evaluation of mucosal function.  This ratio tends to 
decrease with small intestinal disease because xylose absorption is decreased. This 
demonstrates reduced absorption and decrease in mucosal function.  An increase in the 
X:M ratio is of no known significance other than the possibility that it may represent 
recovery or improvement in dogs that previously had abnormal values.  Three values 
were zero (Fig 7) because the dogs vomited the sugar solution and could not be assessed 
during that sample collection period.  Only two dogs had a slightly decreased ratio but 
the overall changes were not significant for any diet, or for sensitized versus control 
dogs.  Because there was not a statistically significant difference in mucosal function or 
IgE levels measured by ELISA, it is reasonable to consider that the differences between 
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sensitized dogs and non-sensitized control dogs was attributed to the method of 
sensitization.   
 The lactulose to rhamnose ratio (L:R) of percentage of sugar recovery in the 
urine is an assessment of small intestinal permeability.  This ratio tends to increase with 
disease and is an indicator of mucosal damage.  It was hypothesized that dogs sensitized 
to soy antigen might undergo mucosal damage when fed a whole soy diet due to 
inflammation associated with dietary hypersensitivity.  Further, it was hypothesized that 
mucosal damage might allow increased permeability of antigen leading to increases in 
IgE measured by serum ELISA.  One non-sensitized dog (#204) had an extremely high 
lactulose value after eating the washout diet.  This was a true outlier and the abnormal 
value cannot be explained as her other samples were within normal limits.  Two dogs 
had an increase in the L:R ratio after eating whole soy (one sensitized, one control) and 
two dogs had an increase in L:R after eating hydrolyzed soy (both sensitized).  The 
remainder of the dogs was within normal limits for the duration of the study.  When the 
sensitized dogs were compared to the non-sensitized control dogs using ANOVA,  there 
was no significant difference (p=0.84).  Critical review of the study would lead to the 
conclusion that the sensitized dogs were not different than the non-sensitized control 
dogs with respect to intestinal permeability as measured by L:R. Previous studies have 
demonstrated that dogs with clinical dietary hypersensitivity had improvement in 
intestinal permeability after being fed an elimination diet14.  The current study did not 
demonstrate similar findings.  Although the sample size was small, this study suggests 
that the atopic dog model may not be suitable for further studies associated with 
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measurement of intestinal permeability if the route of sensitization is subcutaneous 
injection.  
It might be interesting to use the genetic offspring of the atopic dog model and 
attempt to sensitize the dogs by oral rather than subcutaneous route.  By repeating the 
sugar and IgE evaluation tests, it might be possible to demonstrate that this model may 
more closely resemble the population of dogs that have dietary hypersensitivity. 
Conclusions 
This study was designed to evaluate the atopic dog model, the effects of diet on 
IgE production and gastrointestinal permeability and mucosal function, the methods of 
evaluation of IgE detection by ELISA and intradermal testing, and evaluation of soy 
protein antigens in sensitized versus non- sensitized dogs.  Overall, diet did not have a 
statistically significant effect on IgE detected by ELISA or assessed by intradermal skin 
testing.  There were no statistically significant differences between sensitized and non-
sensitized control dogs with respect to gastrointestinal permeability or mucosal function 
evaluation, for any diet.  Soy specific IgE was significantly different between sensitized 
and non-sensitized control dogs as measured by ELISA, but there was no statistically 
significant effect of diet.  Intradermal skin testing yielded a high sensitivity (84%) and 
high specificity at a testing concentration of 1:10 W/V.  These data were different than 
those reported for dogs with naturally occurring dietary hypersensitivity.  Lastly, 
immunoblot analysis demonstrated important soy antigens, mostly subunits of the 7S 
globulin fraction.  There were differences between sensitized dogs and non-sensitized 
control dogs that correlated with ELISA values.  Diet did not influence IgE ELISA 
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values and similar results were seen with Western blot analysis.  Because diet had no 
influence on any parameter of the study, it can be concluded that the atopic dog model 
does not represent dietary hypersensitivity.  IgE antibodies induced by subcutaneous 
sensitization are not synonymous with food allergy.  
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APPENDIX 
IGE ANTIBODIES TO SOY ANTIGENS,  IN SENSITIZED AND 
CONTROL DOGS, DETECTED BY WESTERN BLOT ANALYSIS 
AND ELISA. 
 
Kennis RA1, Tizard I2, Hannah S3, Ermel R2, Bauer J1 
 
1. Texas Veterinary Medical Center, Department of Small Animal Medicine and 
Surgery, Texas A&M University, College Station, TX  77843-4474 
2. Texas Veterinary Medical Center, Department of Pathobiology, Texas A&M 
University, College Station, TX  77843-4467 
3. Ralston Purina Company, Pet Products Group, Checkerboard Square, St. Louis, MO  
63164 
 
Funding:  Sponsored by a research grant through Ralston Purina Company 
 
The objective of the study was to test the hypothesis that dogs sensitized with whole soy 
antigen would produce higher levels of IgE antibodies to soy, compared to non-
sensitized control dogs.  Further, we investigated the IgE binding to whey and globulin 
fractions of soy antigens by immunoblotting with the sera of sensitized and control dogs. 
 
Methods:  8 intact (6 female, 2 male) dogs from a single litter were sensitized to whole 
soy antigen beginning shortly after birth, in a manner previously described.  7 intact (4 
female, 3 male) mixed breed dogs, roughly age matched (1.5-2 years), served as 
controls.  All dogs were fed a pelleted soy free diet (rice flour and egg) for 6 weeks.  
Serum samples were collected and frozen (–20c) until analysis.  Blinded serum samples 
were sent to an outside laboratory (Greer Laboratory) for ELISA analysis.  Soy 
proteins were separated into whey and globulin components and analysed by 15% SDS-
PAGE.  Immunoblottting for IgE was performed from the sera of each dog.   
 
Results:  ELISA test results were presented in terms of relative values (%R) with respect 
to pooled canine sera.  A Student’s T-test showed that there was a statistically significant 
difference (p< 0.003) between the sensitized and control dogs.  Western blot analysis 
showed that IgE binding to whey and globulin protein fractions of soy was variable 
among all dogs.   
 
Conclusions:  These data validate the model and methodologies necessary for the further 
investigation of canine IgE to soy antigens.  
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CHANGES IN IGE ANTIBODIES TO SOY IN SENSITIZED AND 
CONTROL DOGS DETECTED BY ELISA AFTER CHALLENGE 
WITH THREE DIFFERENT DIETS, IN A CROSS-OVER STUDY. 
 
Kennis RA1, Tizard I2, Hannah S3, Ermel R2, Dziezyc J1, Bauer JE1 
 
1. Texas Veterinary Medical Center, Department of Small Animal Medicine and Surgery, Texas A&M 
University, College Station, TX  77843-4474 
2. Texas Veterinary Medical Center, Department of Pathobiology, Texas A&M 
University, College Station, TX  77843-4467 
3. Ralston Purina Company, Pet Products Group, Checkerboard Square, St. Louis, MO  
63164 
Funding:  Sponsored by a research grant through Ralston Purina Company 
 
The objective of the study was to test the hypothesis that sensitized and control dogs 
would produce higher levels of IgE antibodies to soy after being challenged with a 
whole soy diet, compared with an egg based diet (elimination diet), and challenges by a 
hydrolyzed soy diet, and corn based (non-soy) diet. 
 
Methods:  8 dogs were sensitized with 6 food allergens by subcutaneous injections.  
Seven dogs (roughly age matched) were used as non-sensitized control dogs. All dogs 
were fed an elimination diet containing egg and Brewer’s rice (to neither of which any 
dog had been sensitized) for 6 weeks. Serum samples were collected and frozen (-20C) 
until submission to Greer Laboratories  for ELISA analysis.  The dogs were split into 3 
groups and were fed a pelleted diet consisting of either hydrolyzed soy and corn starch 
(Purina HA), intact soy and corn starch, or intact corn (non-soy) diet.  After a 3 week 
challenge, serum samples were collected and submitted.  All dogs were placed on the 
elimination diet for 6 weeks prior to group cross-over and challenge.   
 
Results:  ELISA test results were presented in terms of relative values (%R) with respect 
to pooled canine sera.  There was a statistically significant difference between sensitized 
and control dogs (p< 0.0003) for all diets including the elimination diet.  There was not a 
statistically significant difference in serum IgE levels to soy for any of the diets. 
 
Conclusions:  We were unable to reject the null hypothesis that sensitized and control 
dogs would produce higher levels of IgE to soy when challenged with a whole soy diet, 
compared with challenges by a hydrolyzed soy diet (Purina HA) and corn based (non-
soy) challenges.   
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Nutritional Information 
 
Diet 1 Diet 2 Diet 3 Diet 4
No soy, No corn Modified soy, corn starch Soy based diet Corn based diet
Brewer's Rice X X
Corn Starch X X
Corn X
Egg Albumin X
Modified Soy Protein X
Soy Protein X
Moisture (%) 7.8 8.02 8.73 8.23
Protein (%) 24.4 22.2 21.7 22.8
Fat (%) 10.1 10.9 9.58 11.5
Fiber (%) 2.99 3  
 
All diets contained the same amounts of additives including: 
canola oil, coconut oil, cellulose, calcium carbonate, dicalcium phosphate, potassium 
chloride, nutroloid fiber plus, trace mineral mix, choline chloride, magnesium oxide, 
salt, vitamin mix, selenium, flavor mix, and vitamin E 
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